drug · Product Intelligence

Lorcaserin
Pipeline Intelligence

Lorcaserin: 2 indexed trials, 2 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
2Indexed trials
▦
2Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT02932215New York State Psychiatric Institute · substance_usePHASE1
NCT04572243Eisai Inc. · epilepsyPHASE3

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.